Northwell Health & Business France Sign Transatlantic Alliance Incentivizing Collaborative Innovation in Healthcare

Northwell Health, a leading U.S. medical care provider and the largest health system in New York State, has signed a collaborative agreement with Business France, the trade and investment arm of the French government supporting the growth and expansion of French companies.

Northwell Health notes that the goal of the alliance is to enable collaboration opportunities for French companies and Northwell Health through Business France’s infrastructure.  French companies benefit from access to Northwell’s leaders, scientists and clinical experts for opportunities for sales, co-development and pilots or venture investment. For Northwell, it expands the reach and access to innovative solutions that enhance patient care.

Senior leaders from Northwell Health and Business France executed the memorandum of understanding (MoU) at the Consulate General of France in New York City this month at a reception hosted by Consul General Jérémie Robert. In addition to the formal MOU signing, Northwell hosted a delegation of more than 30 C-level executives from hospitals and healthcare organizations across France visiting New York. The most senior member of the delegation was Mr. Martin Hirsch, CEO of Assistance Publique – Hôpitaux de Paris (AP-HP), the largest health system in France.  The delegates were treated to informative presentations by top Northwell leaders, as well as to a tour of the ER, radiological suite and telepsychiatry center of Lenox Health Greenwich Village, one of Northwell’s flagship Manhattan sites.

“The alliance with Business France is an integral part of Northwell’s continuous efforts to identify breakthrough healthcare innovations, invest in novel technologies, and advance the overall future of health care,” said Michael J. Dowling, president and CEO of Northwell Health. “We look forward to a long, mutually beneficial, collaborative relationship with Business France and the organizations they support.”

Northwell Health has been developing a relationship with Business France and their companies for the past year through the health system’s Global Strategic Partnerships (GSP) International Program, an initiative to establish alliances with government-supported trade agencies as a centralized access point to innovative businesses and technologies. GSP was created to help position Northwell nationally and internationally as a leading destination for partnership, collaboration and innovation. In addition to this latest affiliation, Northwell has forged formal alliances with Enterprise Ireland in 2016 (and renewed in November 2021) and Israel Economic Mission in 2017.

As a means of initiating the organizations’ collaborative relationship, GSP participated in the Business France NEXT French Healthcare accelerator program last October, screening 10 companies, and subsequently meeting and providing insight and guidance to six of those companies. Northwell plans to continue participating in upcoming accelerator programs throughout 2022. Furthermore, GSP leadership engaged with Business France executives at last year’s annual Prix Galien Conference, a life science forum of leading biomedical experts and executives focusing on global healthcare challenges and industry innovations.

“As a business facilitator for both American and French companies, we are always looking to build new bridges between both ecosystems. Today, we are proud to count New York’s largest healthcare provider as a new partner. We are convinced that this new agreement will contribute to accelerating innovation in healthcare, helping us all tackle current and upcoming health challenges,” said Frédéric Rossi, Managing Director, Business France North America.

In addition to delivering healthcare to more than two million people annually and serving as the largest private employer in New York, Northwell Health focuses on a wide range of additional enterprises, including research and innovation, holdings and ventures, and medical educational programs. The health system’s mission includes cultivating innovative ideas and advancing medical technology across the health care landscape in order to transform medical care and improve patient experience.

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.